Inactive Instrument
EntreMed Inc Stock Nasdaq
Stocks
US29382F2020
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 3.41M 2.98M 2.75M 2.54M 4.78M 329M 4.89M 32.89M 12.94M 161M 12.81M 12.53M 554M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 22.08M 20.37M 18.78M 35.4M 2.43B 36.18M 244M 95.79M 1.19B 94.89M 92.81M 4.1B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.85% | -0.80% | +52.79% | +159.97% | 1,051B | ||
| +1.23% | -1.53% | +54.58% | +59.41% | 609B | ||
| +0.04% | +2.58% | +34.47% | +84.84% | 450B | ||
| -0.15% | +0.54% | +30.09% | +21.44% | 330B | ||
| -0.94% | -0.72% | +35.10% | +35.99% | 284B | ||
| -0.25% | -0.49% | +22.63% | +17.31% | 263B | ||
| +0.23% | +1.63% | -19.76% | -40.28% | 223B | ||
| -1.42% | +0.80% | +24.27% | +57.85% | 198B | ||
| -1.48% | +3.43% | +24.08% | +70.06% | 167B | ||
| Average | -0.19% | +0.54% | +28.69% | +51.84% | 397.23B | |
| Weighted average by Cap. | +0.24% | +0.02% | +37.62% | +77.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.94M 23.01M 21.21M 39.98M 2.75B 40.87M 275M 108M 1.35B 107M 105M 4.63B | 20.71M 18.1M 16.7M 15.4M 29.02M 1.99B 29.66M 200M 78.52M 977M 77.78M 76.08M 3.36B |
| Net income | -39.26M -34.31M -31.66M -29.18M -55M -3.78B -56.22M -378M -149M -1.85B -147M -144M -6.37B | -48.06M -42M -38.75M -35.72M -67.33M -4.63B -68.82M -463M -182M -2.27B -180M -177M -7.8B |
| Net Debt | 6.05M 5.29M 4.88M 4.5M 8.48M 583M 8.66M 58.31M 22.94M 285M 22.72M 22.22M 982M | 21.85M 19.1M 17.62M 16.24M 30.62M 2.1B 31.3M 211M 82.85M 1.03B 82.07M 80.27M 3.55B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















